Synthesis,characterization and immobilization of a novel mononuclear vanadium (V) complex on modified magnetic nanoparticles as catalyst for epoxidation of allyl alcohols

The 2,4,6‐tris(2‐pyridyl)‐1,3,5‐triazine (tptz) undergoes hydrolysis in the presence of VO(SO₄) in an alkaline solution, affording mainly the bis(2‐pyridyl carbonyl)amid ) VO₂ complex, designated as [VO₂(bpca)]. Single‐crystal X‐ray crystallography revealed that the coordination of V in complex is a distorted square‐pyramid coordinated with three nitrogen of bis(2‐pyridyl carbonyl)amid ) ligand and two binding oxygen atoms. The prepared complex which successfully supported on modified Fe₃O₄ nanoparticles using tetraethylorthosilicate (TEOS) and (3‐aminopropyl)trimethoxysilane(APTMS)was designated as Fe₃O₄@SiO₂@APTMS@[VO₂(bpca)] complex (nanocatalyst). The complex and nanocatalyst were characterized by means of FT‐IR, XRD, VSM, SEM and TEM. The catalytic activity of [VO₂(bpca)] complex and Fe₃O₄@SiO₂@APTMS@complex as catalysts 1 and 2 were evaluated by the epoxidation of geraniol , 3‐methyl‐2‐buten‐1‐ol , trans‐2‐hexen‐1‐ol and 1‐octen‐3‐ol with 70–98% conversions and 95–100% selectivities. Based on the obtained results, the heterogeneity and reusability of the catalyst seems promising. In addition, the in vitro antibacterial activity of [VO₂ (bpca)] complex have also been evaluated and compared to the activities of other vanadium complexes, tptz ligand and two standard antibacterial drugs, Nalidixic acid and Vancomycin.